<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Genetic correlation between amyotrophic lateral sclerosis and schizophrenia</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-03-21">21 Mar 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Russell</forename><forename type="middle">L</forename><surname>Mclaughlin</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Academic Unit of Neurology</orgName>
								<orgName type="institution" key="instit1">Trinity Biomedical Sciences Institute</orgName>
								<orgName type="institution" key="instit2">Trinity College Dublin</orgName>
								<address>
									<postCode>DO2 DK07</postCode>
									<settlement>Dublin</settlement>
									<country>Republic of Ireland</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Smurfit Institute of Genetics</orgName>
								<orgName type="institution" key="instit2">Trinity College Dublin</orgName>
								<address>
									<postCode>D02 DK07</postCode>
									<settlement>Dublin</settlement>
									<country>Republic of Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dick</forename><surname>Schijven</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Neurology and Neurosurgery</orgName>
								<orgName type="department" key="dep2">Brain Center Rudolf Magnus</orgName>
								<orgName type="institution">University Medical Center Utrecht</orgName>
								<address>
									<postCode>3584 CX</postCode>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">Brain Center Rudolf Magnus</orgName>
								<orgName type="institution">University Medical Center Utrecht</orgName>
								<address>
									<postCode>3584 CX</postCode>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wouter</forename><surname>Van Rheenen</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Neurology and Neurosurgery</orgName>
								<orgName type="department" key="dep2">Brain Center Rudolf Magnus</orgName>
								<orgName type="institution">University Medical Center Utrecht</orgName>
								<address>
									<postCode>3584 CX</postCode>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kristel</forename><forename type="middle">R</forename><surname>Van Eijk</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Neurology and Neurosurgery</orgName>
								<orgName type="department" key="dep2">Brain Center Rudolf Magnus</orgName>
								<orgName type="institution">University Medical Center Utrecht</orgName>
								<address>
									<postCode>3584 CX</postCode>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Margaret</forename><surname>O'brien</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Academic Unit of Neurology</orgName>
								<orgName type="institution" key="instit1">Trinity Biomedical Sciences Institute</orgName>
								<orgName type="institution" key="instit2">Trinity College Dublin</orgName>
								<address>
									<postCode>DO2 DK07</postCode>
									<settlement>Dublin</settlement>
									<country>Republic of Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rene</forename><forename type="middle">´s</forename><surname>Kahn</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">Brain Center Rudolf Magnus</orgName>
								<orgName type="institution">University Medical Center Utrecht</orgName>
								<address>
									<postCode>3584 CX</postCode>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Roel</forename><forename type="middle">A</forename><surname>Ophoff</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">Brain Center Rudolf Magnus</orgName>
								<orgName type="institution">University Medical Center Utrecht</orgName>
								<address>
									<postCode>3584 CX</postCode>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Human Genetics</orgName>
								<orgName type="department" key="dep2">David Geffen School of Medicine</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<postCode>90095</postCode>
									<settlement>Los Angeles</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Center for Neurobehavioral Genetics</orgName>
								<orgName type="laboratory">Semel Institute for Neuroscience and Human Behavior</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<postCode>90095</postCode>
									<settlement>Los Angeles</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">An</forename><surname>Goris</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND)</orgName>
								<orgName type="institution">KU Leuven-University of Leuven</orgName>
								<address>
									<postCode>B-3000</postCode>
									<settlement>Leuven</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Daniel</forename><forename type="middle">G</forename><surname>Bradley</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Smurfit Institute of Genetics</orgName>
								<orgName type="institution" key="instit2">Trinity College Dublin</orgName>
								<address>
									<postCode>D02 DK07</postCode>
									<settlement>Dublin</settlement>
									<country>Republic of Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ammar</forename><surname>Al-Chalabi</surname></persName>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Department of Basic and Clinical Neuroscience</orgName>
								<orgName type="department" key="dep2">Wohl Clinical Neuroscience Institute</orgName>
								<orgName type="institution">King&apos;s College London</orgName>
								<address>
									<postCode>WC2R 2LS</postCode>
									<settlement>London</settlement>
									<country>Maurice, UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Leonard</forename><forename type="middle">H</forename><surname>Van Den Berg</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Neurology and Neurosurgery</orgName>
								<orgName type="department" key="dep2">Brain Center Rudolf Magnus</orgName>
								<orgName type="institution">University Medical Center Utrecht</orgName>
								<address>
									<postCode>3584 CX</postCode>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jurjen</forename><forename type="middle">J</forename><surname>Luykx</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Neurology and Neurosurgery</orgName>
								<orgName type="department" key="dep2">Brain Center Rudolf Magnus</orgName>
								<orgName type="institution">University Medical Center Utrecht</orgName>
								<address>
									<postCode>3584 CX</postCode>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">Brain Center Rudolf Magnus</orgName>
								<orgName type="institution">University Medical Center Utrecht</orgName>
								<address>
									<postCode>3584 CX</postCode>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department">Department of Psychiatry</orgName>
								<orgName type="institution">Hospital Network Antwerp (ZNA) Stuivenberg and Sint Erasmus</orgName>
								<address>
									<postCode>2020</postCode>
									<settlement>Antwerp</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Orla</forename><surname>Hardiman</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Smurfit Institute of Genetics</orgName>
								<orgName type="institution" key="instit2">Trinity College Dublin</orgName>
								<address>
									<postCode>D02 DK07</postCode>
									<settlement>Dublin</settlement>
									<country>Republic of Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jan</forename><forename type="middle">H</forename><surname>Veldink</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Neurology and Neurosurgery</orgName>
								<orgName type="department" key="dep2">Brain Center Rudolf Magnus</orgName>
								<orgName type="institution">University Medical Center Utrecht</orgName>
								<address>
									<postCode>3584 CX</postCode>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Genetic correlation between amyotrophic lateral sclerosis and schizophrenia</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-03-21">21 Mar 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">9E45CC526B9839A977DE4AEB48B1FC12</idno>
					<idno type="DOI">10.1038/ncomms14774</idno>
					<note type="submission">Received 6 Jul 2016 | Accepted 3 Feb 2017 |</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:42+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>We have previously shown higher-than-expected rates of schizophrenia in relatives of patients with amyotrophic lateral sclerosis (ALS), suggesting an aetiological relationship between the diseases.</s><s>Here, we investigate the genetic relationship between ALS and schizophrenia using genome-wide association study data from over 100,000 unique individuals.</s><s>Using linkage disequilibrium score regression, we estimate the genetic correlation between ALS and schizophrenia to be 14.3% (7.05-21.6;</s><s>P ¼ 1 Â 10 À 4 ) with schizophrenia polygenic risk scores explaining up to 0.12% of the variance in ALS (P ¼ 8.4 Â 10 À 7 ).</s><s>A modest increase in comorbidity of ALS and schizophrenia is expected given these findings (odds ratio 1.08-1.26)</s><s>but this would require very large studies to observe epidemiologically.</s><s>We identify five potential novel ALS-associated loci using conditional false discovery rate analysis.</s><s>It is likely that shared neurobiological mechanisms between these two disorders will engender novel hypotheses in future preclinical and clinical studies.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>A myotrophic lateral sclerosis (ALS) is a late-onset neurodegenerative condition characterized by progressive loss of upper and lower motor neurons, leading to death from respiratory failure in 70% of patients within 3 years of symptom onset.</s><s>Although ALS is often described as a primarily motor-system disease, extramotor involvement occurs in up to 50% of cases, with prominent executive and behavioural impairment, and behavioural variant frontotemporal dementia (FTD) in up to 14% of cases <ref type="bibr" target="#b0">1</ref> .</s><s>A neuropsychiatric prodrome has been described in some people with ALS-FTD, and higher rates of schizophrenia and suicide have been reported in first and second degree relatives of those with ALS, particularly in kindreds associated with the C9orf72 hexanucleotide repeat expansion <ref type="bibr" target="#b1">2</ref> .</s><s>These clinical and epidemiological observations suggest that ALS and schizophrenia may share heritability.</s></p><p><s>ALS and schizophrenia both have high heritability estimates (0.65 and 0.64, respectively) <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b3">4</ref> ; however the underlying genetic architectures of these heritable components appear to differ.</s><s>Analysis of large genome-wide association study (GWAS) datasets has implicated over 100 independent risk loci for schizophrenia <ref type="bibr" target="#b4">5</ref> and estimated that a substantial proportion (23%) of the variance in underlying liability for schizophrenia is due to additive polygenic risk (many risk-increasing alleles of low individual effect combining to cause disease) conferred by common genetic variants <ref type="bibr" target="#b5">6</ref> .</s><s>This proportion, the single nucleotide polymorphism (SNP)-based heritability, is lower in ALS (8.2%), in which fewer than ten risk loci have been identified by GWAS <ref type="bibr" target="#b6">7</ref> .</s><s>Nevertheless, both diseases have polygenic components, but the extent to which they overlap has not been investigated.</s></p><p><s>Recently, methods to investigate overlap between polygenic traits using GWAS data have been developed <ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref> .</s><s>These methods assess either pleiotropy (identical genetic variants influencing both traits) or genetic correlation (identical alleles influencing both traits).</s><s>Genetic correlation is related to heritability; for both measures, binary traits such as ALS and schizophrenia are typically modelled as extremes of an underlying continuous scale of liability to develop the trait.</s><s>If two binary traits are genetically correlated, their liabilities covary, and this covariance is determined by both traits having identical risk alleles at overlapping risk loci.</s><s>Studies of pleiotropy and genetic correlation have provided insights into the overlapping genetics of numerous traits and disorders, although none to date has implicated shared polygenic risk between neurodegenerative and neuropsychiatric disease.</s><s>Here, we apply several techniques to identify and dissect the polygenic overlap between ALS and schizophrenia.</s><s>We provide evidence for genetic correlation between the two disorders which is unlikely to be driven by diagnostic misclassification and we demonstrate a lack of polygenic overlap between ALS and other neuropsychiatric and neurological conditions, which could be due to limited power given the smaller cohort sizes for these studies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genetic correlation between ALS and schizophrenia.</head><p><s>To investigate the polygenic overlap between ALS and schizophrenia, we used individual-level and summary data from GWAS for ALS <ref type="bibr" target="#b6">7</ref> (36,052 individuals) and schizophrenia <ref type="bibr" target="#b4">5</ref> (79,845 individuals).</s><s>At least 5,582 control individuals were common to both datasets, but for some cohorts included in the schizophrenia dataset this could not be ascertained so this number is likely to be higher.</s><s>For ALS, we used summary data from both mixed linear model association testing <ref type="bibr" target="#b10">11</ref> and meta-analysis of cohort-level logistic regression <ref type="bibr" target="#b11">12</ref> .</s><s>We first used linkage disequilibrium (LD) score regression with ALS and schizophrenia summary statistics; this technique models, for polygenic traits, a linear relationship between a SNP's LD score (the amount of genetic variation that it captures) and its GWAS test statistic <ref type="bibr" target="#b12">13</ref> .</s><s>This distinguishes confounding from polygenicity in GWAS inflation and the regression coefficient can be used to estimate the SNP-based heritability (h S 2 ) for single traits <ref type="bibr" target="#b12">13</ref> .</s><s>In the bivariate case, the regression coefficient estimates genetic covariance (r g ) for pairs of traits, from which genetic correlation (r g ) is estimated <ref type="bibr" target="#b7">8</ref> ; these estimates are unaffected by sample overlap between traits.</s><s>Using constrained intercept LD score regression with mixed linear model ALS summary statistics, we estimated the liability-scale SNP-based heritability of ALS to be 8.2% (95% confidence interval ¼ 7.2-9.1;</s><s>mean w 2 ¼ 1.13; all ranges reported below indicate 95% confidence intervals), replicating previous estimates based on alternative methods <ref type="bibr" target="#b6">7</ref> .</s><s>Estimates based on ALS meta-analysis summary statistics and free-intercept LD score regression with mixed linear model summary statistics were lower (Supplementary Table <ref type="table">1</ref>), resulting in higher genetic correlation estimates (Supplementary Table <ref type="table">2</ref>); for this reason, we conservatively use constrained intercept genetic correlation estimates for ALS mixed linear model summary statistics throughout the remainder of this paper.</s><s>Heritability estimates for permuted ALS data were null (Supplementary Table <ref type="table">1</ref>).</s></p><p><s>LD score regression estimated the genetic correlation between ALS and schizophrenia to be 14.3% (7.05-21.6;</s><s>P ¼ 1 Â 10 À 4 ).</s><s>Results were similar for a smaller schizophrenia cohort of European ancestry (21,856 individuals) <ref type="bibr">14</ref> , indicating that the inclusion of individuals of Asian ancestry in the schizophrenia cohort did not bias this result (Supplementary Fig. <ref type="figure">1</ref>).</s><s>In addition to schizophrenia, we estimated genetic correlation with ALS using GWAS summary statistics for bipolar disorder <ref type="bibr" target="#b14">15</ref> , major depressive disorder <ref type="bibr" target="#b15">16</ref> , attention deficit-hyperactivity disorder <ref type="bibr" target="#b16">17</ref> , autism spectrum disorder 17 , Alzheimer's disease (Supplementary Note 1) <ref type="bibr" target="#b17">18</ref> , multiple sclerosis <ref type="bibr" target="#b18">19</ref> and adult height <ref type="bibr" target="#b19">20</ref> , finding no significant genetic correlation between ALS and any secondary trait other than schizophrenia (Fig. <ref type="figure">1</ref>; Supplementary Table <ref type="table">2</ref>).</s></p><p><s>Polygenic risk score analysis.</s><s>We supported the positive genetic correlation between ALS and schizophrenia by analysis of polygenic risk for schizophrenia in the ALS cohort.</s><s>Polygenic risk scores (PRS) are per-individual scores based on the sum of alleles associated with one phenotype, weighted by their effect size, measured in an independent target sample of the same or a different phenotype <ref type="bibr" target="#b9">10</ref> .</s><s>PRS calculated on schizophrenia GWAS summary statistics for twelve P-value thresholds (P T ) explained up to 0.12% (P T ¼ 0.2, P ¼ 8.4 Â 10 À 7 ) of the phenotypic variance in a subset of the individual-level ALS genotype data that had all individuals removed that were known or suspected to be present in the schizophrenia cohort (Fig. <ref type="figure" target="#fig_0">2</ref>; Supplementary Table <ref type="table">5</ref>).</s><s>ALS cases had on average higher PRS for schizophrenia compared to healthy controls and harbouring a high schizophrenia PRS for P T ¼ 0.2 significantly increased the odds of being an ALS patient in our cohort (Fig. <ref type="figure" target="#fig_1">3</ref>; Supplementary Table <ref type="table">6</ref>).</s><s>Permutation of case-control labels reduced the explained variance to values near zero (Supplementary Fig. <ref type="figure" target="#fig_1">3</ref>).</s></p><p><s>Modelling misdiagnosis and comorbidity.</s><s>Using BUHMBOX <ref type="bibr" target="#b20">21</ref> , a tool that distinguishes true genetic relationships between diseases (pleiotropy) from spurious relationships resulting from heterogeneous mixing of disease cohorts, we determined that misdiagnosed cases in the schizophrenia cohort (for example, young-onset FTD-ALS) did not drive the genetic correlation estimate between ALS and schizophrenia (P ¼ 0.94).</s><s>Assuming a true genetic correlation of 0%, we estimated the required rate of misdiagnosis of ALS as schizophrenia to be 4.86% (2.47-7.13) to obtain the genetic correlation estimate of 14.3% (7.05-21.6;</s><s>Supplementary Table <ref type="table">7</ref>), which we consider to be too high to be likely.</s><s>However, if ALS and schizophrenia are genetically correlated, more comorbidity would be expected than if the genetic correlation was 0%.</s><s>Modelling our observed genetic correlation of 14.3% (7.05-21.6),</s><s>we estimated the odds ratio for having above-threshold liability for ALS given above-threshold liability for schizophrenia to be 1.17 (1.08-1.26),</s><s>and the same for schizophrenia given ALS (Supplementary Fig. <ref type="figure" target="#fig_2">4</ref>).</s><s>From a clinical perspective, to achieve 80% power to detect a significant (a ¼ 0.05) excess of schizophrenia in the ALS cohort as a result of this genetic correlation, the required population-based incident cohort size is 16,448 ALS patients (7,310-66,670).</s><s><ref type="table">4</ref>) and including sex and significant principal components as covariates (Supplementary Fig. <ref type="figure" target="#fig_0">2</ref>).</s><s>Values are provided in Supplementary Table <ref type="table">5</ref>. Pleiotropic risk loci.</s><s>We leveraged the genetic correlation between ALS and schizophrenia to discover novel ALS-associated genomic loci by conditional false discovery rate (cFDR) analysis <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b21">22</ref> (Fig. <ref type="figure" target="#fig_2">4</ref>; Supplementary Table <ref type="table">8</ref>).</s><s>Five loci already known to be involved in ALS were identified (corresponding to MOBP, C9orf72, TBK1, SARM1 and UNC13A) along with five potential novel loci at cFDRo0.01 (CNTN6, TNIP1, PPP2R2D, NCKAP5L and ZNF295-AS1).</s><s>No gene set was significantly enriched (after Bonferroni correction) in genome-wide cFDR values when analysed using MAGENTA.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>There is evolving clinical, epidemiological and biological evidence for an association between ALS and psychotic illness, particularly schizophrenia.</s><s>Genetic evidence of overlap to date has been based primarily on individual genes showing Mendelian inheritance, in particular the C9orf72 hexanucleotide repeat expansion, which is associated with ALS and FTD, and with psychosis in relatives of ALS patients <ref type="bibr" target="#b1">2</ref> .</s><s>In this study, we have replicated SNP-based heritability estimates for ALS and schizophrenia using GWAS summary statistics, and have for the first time demonstrated significant overlap between the polygenic components of both diseases, estimating the genetic correlation to be 14.3%.</s><s>We have carefully controlled for confounding bias, including population stratification and shared control samples, and have shown through analysis of polygenic risk scores that the overlapping polygenic risk applies to SNPs that are modestly associated with both diseases.</s><s>Given that our genetic correlation estimate relates to the polygenic components of ALS (h S 2 ¼ 8.2%) and schizophrenia (h S 2 ¼ 23%) and these estimates do not represent all heritability for both diseases, the accuracy of using schizophreniabased PRS to predict ALS status in any patient is expected to be low (Nagelkerke's R 2 ¼ 0.12% for P T ¼ 0.2), although statistically significant (P ¼ 8.4 Â 10 À 7 ).</s><s>Nevertheless, the positive genetic correlation of 14.3% indicates that the direction of effect of risk-increasing and protective alleles is consistently aligned between ALS and schizophrenia, suggesting convergent biological mechanisms between the two diseases.</s></p><p><s>Although phenotypically heterogeneous, both ALS and schizophrenia are clinically recognizable as syndromes <ref type="bibr">23,</ref><ref type="bibr" target="#b23">24</ref> .</s><s>The common biological mechanisms underlying the association between the two conditions are not well understood, but are likely associated with disruption of cortical networks.</s><s>Schizophrenia is a polygenic neurodevelopmental disorder characterized by a combination of positive symptoms (hallucinations and delusions), negative symptoms (diminished motivation, blunted affect, reduction in spontaneous speech and poor social functioning) and impairment over a broad range of cognitive abilities <ref type="bibr" target="#b24">25</ref> .</s><s>ALS is a late onset complex genetic disease characterized by a predominantly motor phenotype with recently recognized extra-motor features in 50% of patients, including cognitive impairment <ref type="bibr" target="#b0">1</ref> .</s><s>It has been suggested that the functional effects of risk genes in schizophrenia converge by modulating synaptic plasticity, and influencing the development and stabilization of cortical microcircuitry <ref type="bibr" target="#b4">5</ref> .</s><s>In this context, our identification of CNTN6 (contactin 6, also known as NB-3, a neural adhesion protein important in axon development) <ref type="bibr" target="#b25">26</ref> as a novel pleiotropy-informed ALS-associated locus supports neural network dysregulation as a potential convergent mechanism of disease in ALS and schizophrenia.</s></p><p><s>No significantly enriched biological pathway or ontological term was identified within genome-wide cFDR values using MAGENTA.</s><s>Low inflation in ALS GWAS statistics, coupled with a rare variant genetic architecture <ref type="bibr" target="#b6">7</ref> , render enrichment-based biological pathway analyses with current sample sizes challenging.</s><s>Nevertheless, nine further loci were associated with ALS risk at cFDR o0.01.</s><s>Of these, MOBP, C9orf72, TBK1, SARM1 and UNC13A have been described previously in ALS and were associated by cFDR analysis in this study owing to their strong association with ALS through GWAS <ref type="bibr" target="#b6">7</ref> .</s><s>The remaining four loci (TNIP1, PPP2R2D, NCKAP5L and ZNF295-AS1) are novel associations and may represent pleiotropic disease loci.</s><s>TNIP1 encodes TNFAIP3 interacting protein 1 and is involved in autoimmunity and tissue homoeostasis <ref type="bibr" target="#b26">27</ref> .</s><s>The protein product of PPP2R2D is a regulatory subunit of protein phosphatase 2 and has a role in PI3K-Akt signalling and mitosis <ref type="bibr" target="#b27">28</ref> .</s><s>NCKAP5L is a homologue of NCKAP5, encoding NAP5, a proline-rich protein that has previously been implicated in schizophrenia, bipolar disorder and autism <ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b29">30</ref> .</s><s>ZNF295-AS1 is a noncoding RNA <ref type="bibr" target="#b30">31</ref> .</s><s>Further investigation into the biological roles of these genes may yield novel insight into the pathophysiology of certain subtypes of ALS and schizophrenia, and as whole-genome and exome datasets become available in the future for appropriately large ALS case-control cohorts, testing for burden of rare genetic variation across these genes will be particularly instructive, especially given the role that rare variants appear to play in the pathophysiology of ALS 7 .</s><s><ref type="table">8</ref>.</s></p><p><s>Our data suggest that other neuropsychiatric conditions (bipolar disorder, autism and major depression) do not share polygenic risk with ALS.</s><s>This finding contrasts with our recent observations from family aggregation studies and may be unexpected given the extensive genetic correlation between neuropsychiatric conditions <ref type="bibr" target="#b5">6</ref> .</s><s>This could relate to statistical power conferred by secondary phenotype cohort sizes, and future studies with larger sample sizes will shed further light on the relationship between ALS and neuropsychiatric disease.</s><s>It is also possible that the current study underestimates genetic correlations due to the substantial role that rare variants play in the genetic architecture of ALS <ref type="bibr" target="#b6">7</ref> and future fine-grained studies examining heritability and genetic correlation in low-minor allele frequency and low-LD regions may identify a broader relationship between ALS and neuropsychiatric diseases.</s></p><p><s>A potential criticism of this study is that the polygenic overlap between ALS and schizophrenia could be driven by misdiagnosis, particularly in cases of ALS-FTD, which can present in later life as a psychotic illness and could be misdiagnosed as schizophrenia.</s><s>This is unlikely, as strict diagnostic criteria are required for inclusion of samples in the schizophrenia GWAS dataset <ref type="bibr" target="#b4">5</ref> .</s><s>Furthermore, since core schizophrenia symptoms are usually diagnosed during late adolescence, a misdiagnosis of FTD-onset ALS-FTD as schizophrenia is unlikely.</s><s>In this study, we found no evidence for misdiagnosis of ALS as schizophrenia (BUHMBOX P ¼ 0.94) and we estimated that a misdiagnosis of 4.86% of ALS cases would be required to spuriously observe a genetic correlation of 14.3%, which is not likely to occur in clinical practice.</s><s>We are therefore confident that this genetic correlation estimate reflects a genuine polygenic overlap between the two diseases and is not a feature of cohort ascertainment, but the possibility of some misdiagnosis in either cohort cannot be entirely excluded based on available data.</s></p><p><s>A positive genetic correlation between ALS and schizophrenia predicts an excess of patients presenting with both diseases.</s><s>Most neurologists and psychiatrists, however, will not readily acknowledge that these conditions co-occur frequently.</s><s>Our genetic correlation estimate confers an odds ratio of 1.17 (1.08-1.26)</s><s>for harbouring above-threshold liability for ALS given schizophrenia (or vice versa) and a lifetime risk of 1:34,336 for both phenotypes together.</s><s>Thus, a very large incident cohort of 16,448 ALS patients (7,310-66,670), with detailed phenotype information, would be required to have sufficient power to detect an excess of schizophrenia within an ALS cohort.</s><s>Coupled with reduced life expectancy in patients with schizophrenia <ref type="bibr" target="#b31">32</ref> , this may explain the relative dearth of epidemiological studies to date providing clinical evidence of excess comorbidity.</s><s>Moreover, it has also been proposed that prolonged use of antipsychotic medication may protect against developing all of the clinical features of ALS <ref type="bibr" target="#b32">33</ref> , which would reduce the rate of observed comorbidity.</s><s>Considering our novel evidence for a genetic relationship between ALS and schizophrenia, this underscores the intriguing possibility that therapeutic strategies for each condition may be useful in the other, and our findings provide rationale to consider the biology of ALS and schizophrenia as related in future drug development studies.</s><s>Indeed, the glutamate-modulating ALS therapy riluzole has shown efficacy as an adjunct to risperidone, an antipsychotic medication, in reducing the negative symptoms of schizophrenia <ref type="bibr" target="#b33">34</ref> .</s></p><p><s>In conclusion, we have estimated the genetic correlation between ALS and schizophrenia to be 14.3% (7.05-21.6),</s><s>providing molecular genetic support for our epidemiological observation of psychiatric endophenotypes within ALS kindreds.</s><s>To our knowledge, this is the first study to show genetic correlation derived from polygenic overlap between neurodegenerative and neuropsychiatric phenotypes.</s><s>The presence of both apparent monogenic C9orf72-driven overlap 2 and polygenic overlap in the aetiology of ALS and schizophrenia suggests the presence of common biological processes, which may relate to disruption of cortical circuitry.</s><s>As both ALS and schizophrenia are heterogeneous conditions, further genomic, biological and clinical studies are likely to yield novel insights into the pathological processes for both diseases and will provide clinical sub-stratification parameters that could drive novel drug development for both neurodegenerative and psychiatric conditions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>Study population and genetic data.</s><s>For ALS, 7,740,343 SNPs genotyped in 12,577 ALS patients and 23,475 healthy controls of European ancestry organized in 27 platform-and country-defined strata were used <ref type="bibr" target="#b6">7</ref> .</s><s>The schizophrenia dataset comprised GWAS summary statistics for 9,444,230 SNPs originally genotyped in 34,241 patients and 45,604 controls of European and Asian ancestry <ref type="bibr" target="#b4">5</ref> .</s><s>For LD score regression, GWAS summary statistics were generated for the ALS cohort using mixed linear model association testing implemented in Genome-wide Complex Trait Analysis <ref type="bibr" target="#b10">11</ref> or logistic regression combined with cross-stratum meta-analysis using METAL <ref type="bibr" target="#b11">12</ref> .</s><s>To evaluate sample overlap for PRS and cFDR analyses, we also obtained individual-level genotype data for 27,647 schizophrenia cases and 33,675 controls from the schizophrenia GWAS (Psychiatric Genomics Consortium 5 and dbGaP accession number phs000021.v3.p2).</s><s>Using 88,971 LD-pruned (window size 200 SNPs; shift 20 SNPs; r 2 40.25)</s><s>SNPs in both datasets (INFO score40.8;</s><s>MAF40.2), with SNPs in high-LD regions removed (Supplementary Table <ref type="table">4</ref>), samples were removed from the ALS dataset if they were duplicated or had a cryptically related counterpart (PLINK p40.1; 5,582 individuals) in the schizophrenia cohort and whole strata (representing Finnish and German samples; 3,811 individuals) were also removed if commonality with the schizophrenia cohort could not be ascertained (due to unavailability of individual-level genotype data in the schizophrenia cohort) and in which a sample overlap was suspected (Supplementary Table <ref type="table">3</ref>).</s><s>LD score regression.</s><s>We calculated LD scores using LDSC v1.0.0 in 1 centiMorgan windows around 13,307,412 non-singleton variants genotyped in 379 European individuals (CEU, FIN, GBR, IBS and TSI populations) in the phase 1 integrated release of the 1,000 Genomes Project <ref type="bibr" target="#b34">35</ref> .</s><s>For regression weights <ref type="bibr" target="#b12">13</ref> , we restricted LD score calculation to SNPs included in both the GWAS summary statistics and HapMap phase 3; for r g estimation in pairs of traits this was the intersection of SNPs for both traits and HapMap.</s><s>Because population structure and confounding were highly controlled in the ALS summary statistics by the use of mixed linear model association tests, we constrained the LD score regression intercept to 1 for h S 2 estimation in ALS, and we also estimated h S 2 with a free intercept.</s><s>For h S 2 estimation in all other traits and for r g estimation the intercept was a free parameter.</s><s>We also estimated r g using ALS meta-analysis results <ref type="bibr" target="#b6">7</ref> with free and constrained intercepts and with permuted data conserving population structure.</s><s>Briefly, principal component analysis was carried out for each stratum using smartpca <ref type="bibr" target="#b35">36</ref> and the three-dimensional space defined by principal components 1-3 was equally subdivided into 1,000 cubes.</s><s>Within each cube, case-control labels were randomly swapped and association statistics were re-calculated for the entire stratum using logistic regression.</s><s>Study-level P-values were then calculated using inverse variance weighted fixed effect meta-analysis implemented in METAL <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b11">12</ref> .</s><s>h S 2 was estimated for these meta-analysed permuted data using LD score regression (Supplementary Table <ref type="table">1</ref>).</s></p><p><s>Polygenic risk score analysis.</s><s>We calculated PRS for 10,032 cases and 16,627 healthy controls in the ALS dataset (duplicate and suspected or confirmed related samples with the schizophrenia dataset removed), based on schizophreniaassociated alleles and effect sizes reported in the GWAS summary statistics for 6,843,674 SNPs included in both studies and in the phase 1 integrated release of the 1,000 Genomes Project <ref type="bibr" target="#b34">35</ref> (imputation INFO score o0.3; minor allele frequency o0.01; A/T and G/C SNPs removed).</s><s>SNPs were clumped in two rounds (physical distance threshold of 250 kb and a LD threshold (R 2 ) of40.5 in the first round and a distance of 5,000 kb and LD threshold of 40.2 in the second round) using PLINK v1.90b3y, removing high-LD regions (Supplementary Table <ref type="table">4</ref>), resulting in a final set of 496,548 SNPs for PRS calculations.</s><s>Odds ratios for autosomal SNPs reported in the schizophrenia summary statistics were log-converted to beta values and PRS were calculated using PLINK's score function for twelve schizophrenia GWAS P-value thresholds (P T ): 5 Â 10 À 8 , 5 Â 10 À 7 , 5 Â 10 À 6 , 5 Â 10 À 5 , 5 Â 10 À 4 , 5 Â 10 À 3 , 0.05, 0.1, 0.2, 0.3, 0.4 and 0.5.</s><s>A total of 100 principal components (PCs) were generated for the ALS sample using GCTA version 1.24.4.</s><s>Using R version 3.2.2, a generalized linear model was applied to model the phenotype of individuals in the ALS dataset.</s><s>PCs that had a significant effect on the phenotype (Po0.0005,</s><s>Bonferroni-corrected for 100 PCs) were selected (PCs 1, 4, 5, 7, 8, 10, 11, 12, 14, 36, 49).</s></p><p><s>To estimate explained variance of PRS on the phenotype, a baseline linear relationship including only sex and significant PCs as variables was modelled first:</s></p><formula xml:id="formula_0">y ¼ a þ b sex x sex þ X n b pc n x pc n ;</formula><p><s>where y is the phenotype in the ALS dataset, a is the intercept of the model with a slope b for each variable x.</s></p><p><s>Subsequently, a linear model including polygenic scores for each schizophrenia P T was calculated:</s></p><formula xml:id="formula_1">y ¼ a þ b sex x sex þ X n b pc n x pc n þ b prs x prs :</formula><p><s>A Nagelkerke R 2 value was obtained for every model and the baseline Nagelkerke R 2 value was subtracted, resulting in a D explained variance that describes the contribution of schizophrenia-based PRS to the phenotype in the ALS dataset.</s><s>PRS analysis was also performed in permuted case-control data (1,000 permutations, conserving case-control ratio) to assess whether the increased D explained variance was a true signal associated with phenotype.</s><s>D explained variances and P-values were averaged across permutation analyses.</s></p><p><s>To ensure we did not over-or under-correct for population effects in our model, we tested the inclusion of up to a total of 30 PCs in the model, starting with the PC with the most significant effect on the ALS phenotype (Supplementary Fig. <ref type="figure" target="#fig_0">2</ref>).</s><s>Increasing the number of PCs initially had a large effect on the D explained variance, but this effect levelled out after 11 PCs.</s><s>On the basis of this test we are confident that adding the 11 PCs that had a significant effect on the phenotype sufficiently accounted for possible confounding due to population differences.</s></p><p><s>For the schizophrenia P T for which we obtained the highest D explained variance (0.2), we subdivided observed schizophrenia-based PRS in the ALS cohort into deciles and calculated the odds ratio for being an ALS case in each decile compared to the first decile using a similar generalized linear model:</s></p><formula xml:id="formula_2">y ¼ a þ b sex x sex þ X n b pc n x pc n þ b decile x decile :</formula><p><s>Odds ratios and 95% confidence intervals for ALS were derived by calculating the exponential function of the beta estimate of the model for each of the deciles 2-10.</s></p><p><s>Diagnostic misclassification.</s><s>To distinguish the contribution of misdiagnosis from true genetic pleiotropy we used BUHMBOX <ref type="bibr" target="#b20">21</ref> with 417 independent ALS risk alleles in a sample of 27,647 schizophrenia patients for which individual-level genotype data were available.</s><s>We also estimated the required misdiagnosis rate M of FTD-ALS as schizophrenia that would lead to the observed genetic correlation estimate as C/(C þ 1), where C ¼ r g N SCZ /N ALS and N SCZ and N ALS are the number of cases in the schizophrenia and ALS datasets, respectively <ref type="bibr" target="#b36">37</ref> (derived in Supplementary Methods 1).</s></p><p><s>Expected comorbidity.</s><s>To investigate the expected comorbidity of ALS and schizophrenia given the observed genetic correlation, we modelled the distribution in liability for ALS and schizophrenia as a bivariate normal distribution with the liability-scale covariance determined by LD score regression (Supplementary Methods 2).</s><s>Lifetime risks for ALS <ref type="bibr" target="#b37">38</ref> and schizophrenia 25 of 1/400 and 1/100, respectively, were used to calculate liability thresholds above which individuals develop ALS or schizophrenia, or both.</s><s>The expected proportions of individuals above these thresholds were used to calculate the odds ratio of developing ALS given schizophrenia, or vice versa (Supplementary Methods 2).</s><s>The required population size to observe a significant excess of comorbidity was calculated using the binomial power equation.</s></p><p><s>Pleiotropy-informed risk loci for ALS.</s><s>Using an adapted cFDR method <ref type="bibr" target="#b8">9</ref> that allows shared controls between cohorts <ref type="bibr" target="#b21">22</ref> , we estimated per-SNP cFDR given LD score-corrected <ref type="bibr" target="#b7">8</ref></s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 2 |</head><label>2</label><figDesc><div><p><s>Figure 2 | Analysis of PRS for schizophrenia in a target sample of 10,032 ALS cases and 16,627 healthy controls.</s><s>P-value thresholds (P T ) for schizophrenia SNPs are shown on the x axis, where the number of SNPs increases with a more lenient P T .</s><s>D Explained variances (Nagelkerke R 2 , shown as a %) of a generalized linear model including schizophrenia-based PRS versus a baseline model without polygenic scores (blue bars) are shown for each P T .</s><s>À Log 10 P-values of D explained variance per P T (red dots) represent P-values from the binomial logistic regression of ALS phenotype on PRS, accounting for LD (Supplementary Table4) and including sex and significant principal components as covariates (Supplementary Fig.2).</s><s>Values are provided in Supplementary Table5.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 3 |</head><label>3</label><figDesc><div><p><s>Figure3| Odds ratio for ALS by PRS deciles for schizophrenia.</s><s>The figure applies to schizophrenia P-value threshold (P T ) ¼ 0.2.</s><s>The PRS for this threshold were converted to ten deciles containing near identical numbers of individuals.</s><s>Decile 1 contained the lowest scores and decile 10 contained the highest scores, where decile 1 was the reference and deciles 2-10 were dummy variables to contrast to decile 1 for OR calculation.</s><s>The case:control ratio per decile is indicated with grey bars.</s><s>Error bars indicate 95% confidence intervals.</s><s>Significant differences from decile 1 were determined by logistic regression of ALS phenotype on PRS decile, including sex and principal components as covariates and are indicated by *Po0.05 or ***Po0.001.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 4 |</head><label>4</label><figDesc><div><p><s>Figure4| Pleiotropy-informed ALS risk loci determined by analysis of cFDR in ALS GWAS P-values given schizophrenia GWAS P-values (cFDR ALS|SCZ ).</s><s>Each point denotes a SNP; its x axis position corresponds to its chromosomal location and its height indicates the extent of association with ALS by cFDR analysis.</s><s>The solid line indicates the threshold cFDR ¼ 0.01.</s><s>Any gene whose role in ALS is already established is in bold.</s><s>A complete list of all loci at cFDRr0.05 is provided in Supplementary Table8.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head></head><label></label><figDesc><div><p><s>39hizophrenia GWAS P-values for ALS mixed linear model summary statistics calculated in a dataset excluding Finnish and German cohorts (in which suspected control overlap could not be determined), but including all other overlapping samples (totalling 5,582).To correct for the relationship between LD and GWAS test statistics, schizophrenia summary statistics were residualized on LD score by subtracting the product of each SNP's LD score and the univariate LD score regression coefficient for schizophrenia.cFDRvaluesconditioned on these residualized schizophrenia GWAS P-values were calculated for mixed linear model association statistics calculated at 6,843,670 SNPs genotyped in 10,147 ALS cases and 22,094 controls.Pleiotropic genomic loci were considered statistically significant if cFDRo0.01 (following Andreassen et al.9) and were clumped with all neighbouring SNPs based on LD (r 2 40.1) in the complete ALS dataset.Associated cFDR genomic regions were then mapped to the locations of known RefSeq transcripts in human genome build GRCh37.Genome-wide cFDR values were also tested for enrichment in 9,711 gene sets included in the MAGENTA software package (version 2.4, July 2011) and derived from databases such as Gene Ontology (GO, http://geneontology.org/), Kyoto Encyclopedia of Genes and Genomes (KEGG, http://www.kegg.jp/),ProteinANalysisTHrough</s><s>Evolutionary Relationships (PANTHER, http://www.pantherdb.org/) and INGENUITY (http://www.ingenuity.com/).SNPs were mapped to genes including 20 kb up-and downstream regions to include regulatory elements.The enrichment cutoff applied in our analysis was based on the 95th percentile of gene scores for all genes in the genome.The null distribution of gene scores for each gene set was based on 10,000 randomly sampled gene sets with equal size.MAGENTA uses a Mann-Whitney rank-sum test to assess gene-set enrichment39.Data availability.</s><s>All data used in this study are publically available and can be accessed via the studies cited in the text.</s><s>Other data are available from the authors upon reasonable request.</s></p></div></figDesc><table /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">NATURE COMMUNICATIONS | 8:14774 | DOI: 10.1038/ncomms14774 | www.nature.com/naturecommunications</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="94">Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.95  Stanley Center for Psychiatric Research, Broad Institute of MI.T. and Harvard, Cambridge, Massachusetts, USA. 96 Medical and Population Genetics Program, Broad Institute of MI.T. and Harvard,</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We acknowledge helpful contributions from Mr Gert Jan van de Vendel in the design and execution of PRS analyses.</s><s>This study received support from the ALS Association; Fondation Thierry Latran; the Motor Neurone Disease Association of England, Wales and Northern Ireland; Science Foundation Ireland; Health Research Board (Ireland), The Netherlands ALS Foundation (Project MinE, to J. ).</s><s>We thank the International Genomics of Alzheimer's Project (IGAP) for providing summary results data for these analyses.</s><s>The investigators within IGAP provided data but did not participate in analysis or writing of this report.</s><s>IGAP was made possible by the generous participation of the control subjects, the patients, and their families.</s><s>The i-Select chips was funded by the French National Foundation on Alzheimer's disease and related disorders.</s><s>EADI was supported by the LABEX (laboratory of excellence program investment for the future) DISTALZ grant, Inserm, Institut Pasteur de Lille, Universite ´de Lille 2 and the Lille University Hospital.</s><s>GERAD was supported by the MRC (Grant No. 5,03,480), Alzheimer's Research UK (Grant No. 5,03,176), the Wellcome Trust (Grant No. 082604/2/07/Z) and German Federal Ministry of Education and Research: Competence Network Dementia Grant no.</s><s>01GI0102, 01GI0711, 01GI0420.</s><s>CHARGE was partly supported by the NIH/NIA Grant R01 AG033193 and the NIA AG081220 and AGES contract N01-AG-12,100, the NHLBI Grant R01 HL105756, the Icelandic Heart Association, and the Erasmus Medical Center and Erasmus University.</s><s>ADGC was supported by the NIH/NIA Grants: U01 AG032984, U24 AG021886, U01 AG016976, and the Alzheimer's Association Grant ADGC-10-196728.</s><s>The Project MinE GWAS Consortium included contributions from the PARALS registry, SLALOM group, SLAP registry, FALS Sequencing Consortium, SLAGEN Consortium and NNIPPS Study Group; the Schizophrenia Working Group of the Psychiatric Genomics Consortium included contributions from the Psychosis Endophenotypes International Consortium and Wellcome Trust Case-control Consortium.</s><s>Members of these eight consortia are listed in Supplementary Note 2.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author contributions</head><p><s>Reprints and permission information is available online at http://npg.nature.com/</s><s>reprintsandpermissions/</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Phukan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurol. Neurosurg. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="102" to="108" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Byrne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="699" to="708" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">An estimate of amyotrophic lateral sclerosis heritability using twin data</title>
		<author>
			<persName><forename type="first">A</forename><surname>Al-Chalabi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurol. Neurosurg. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="1324" to="1326" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study</title>
		<author>
			<persName><forename type="first">P</forename><surname>Lichtenstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Lond. Engl</title>
		<imprint>
			<biblScope unit="volume">373</biblScope>
			<biblScope unit="page" from="234" to="239" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Biological insights from 108 schizophrenia-associated genetic loci</title>
	</analytic>
	<monogr>
		<title level="m">Schizophrenia Working Group of the Psychiatric Genomics Consortium</title>
				<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">511</biblScope>
			<biblScope unit="page" from="421" to="427" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Group of the Psychiatric Genomics Consortium. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs</title>
		<author>
			<persName><surname>Cross-Disorder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="984" to="994" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis</title>
		<author>
			<persName><forename type="first">W</forename><surname>Van Rheenen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1043" to="1048" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">An atlas of genetic correlations across human diseases and traits</title>
		<author>
			<persName><forename type="first">B</forename><surname>Bulik-Sullivan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1236" to="1241" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">A</forename><surname>Andreassen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hum. Genet</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="197" to="209" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Common polygenic variation contributes to risk of schizophrenia and bipolar disorder</title>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">460</biblScope>
			<biblScope unit="page" from="748" to="752" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>International Schizophrenia Consortium</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Advantages and pitfalls in the application of mixed-model association methods</title>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Zaitlen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Goddard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Visscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Price</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="100" to="106" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">METAL: fast and efficient meta-analysis of genomewide association scans</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Willer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Abecasis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2190" to="2191" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">LD Score regression distinguishes confounding from polygenicity in genome-wide association studies</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Bulik-Sullivan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="291" to="295" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study identifies five new schizophrenia loci</title>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="969" to="976" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4</title>
	</analytic>
	<monogr>
		<title level="m">Psychiatric GWAS Consortium Bipolar Disorder Working Group</title>
				<imprint>
			<date type="published" when="2011">2011</date>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="977" to="983" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium. A mega-analysis of genome-wide association studies for major depressive disorder</title>
	</analytic>
	<monogr>
		<title level="j">Mol. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="497" to="511" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis</title>
		<author>
			<persName><surname>Cross-Disorder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Lond. Engl</title>
		<imprint>
			<biblScope unit="volume">381</biblScope>
			<biblScope unit="page" from="1371" to="1379" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Lambert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1452" to="1458" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Patsopoulos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="897" to="912" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Defining the role of common variation in the genomic and biological architecture of adult human height</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Wood</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1173" to="1186" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">A method to decipher pleiotropy by detecting underlying heterogeneity driven by hidden subgroups applied to autoimmune and neuropsychiatric diseases</title>
		<author>
			<persName><forename type="first">B</forename><surname>Han</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="803" to="810" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">A pleiotropy-informed Bayesian false discovery rate adapted to a shared control design finds new disease associations from GWAS summary statistics</title>
		<author>
			<persName><forename type="first">J</forename><surname>Liley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wallace</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">e1004926</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">The prevention of schizophrenia</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Mcgrath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Schizophr. Bull</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="257" to="261" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Amyotrophic lateral sclerosis: moving towards a new classification system</title>
		<author>
			<persName><forename type="first">A</forename><surname>Al-Chalabi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1182" to="1194" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Kahn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Dis. Primer</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">15067</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Loss of neural recognition molecule NB-3 delays the normal projection and terminal branching of developing corticospinal tract axons in the mouse</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shimoda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Comp. Neurol</title>
		<imprint>
			<biblScope unit="volume">520</biblScope>
			<biblScope unit="page" from="1227" to="1245" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Emerging roles for TNIP1 in regulating post-receptor signaling</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Ramirez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gurevich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Aneskievich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cytokine Growth Factor Rev</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="109" to="118" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Signaling specificity in the Akt pathway in biology and disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Toker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Marmiroli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv. Biol. Regul</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="28" to="38" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder</title>
		<author>
			<persName><forename type="first">K.-S</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X.-F</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Aragam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Schizophr. Res</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="192" to="199" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Chahrour</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e1002635</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Complete sequencing and characterization of 21,243 full-length human cDNAs</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ota</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="40" to="45" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Life expectancy and cardiovascular mortality in persons with schizophrenia</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Laursen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Munk-Olsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vestergaard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="83" to="88" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Does treating schizophrenia reduce the chances of developing amyotrophic lateral sclerosis?</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Stommel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Graber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Montanye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Harris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med. Hypotheses</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1021" to="1028" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia</title>
		<author>
			<persName><forename type="first">M</forename><surname>Farokhnia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">231</biblScope>
			<biblScope unit="page" from="533" to="542" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">An integrated map of genetic variation from 1,092 human genomes</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Mcvean</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">491</biblScope>
			<biblScope unit="page" from="56" to="65" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Population structure and eigenanalysis</title>
		<author>
			<persName><forename type="first">N</forename><surname>Patterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Reich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">e190</biblScope>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Impact of diagnostic misclassification on estimation of genetic correlations using genome-wide genotypes</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Wray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Kendler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Hum. Genet</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="668" to="674" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Johnston</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurol</title>
		<imprint>
			<biblScope unit="volume">253</biblScope>
			<biblScope unit="page" from="1642" to="1643" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits</title>
		<author>
			<persName><forename type="first">`</forename><surname>Segre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">e1001058</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">John Hardy 30 , Richard W. Orrell 31 , Alan Pittman 30,32 , Katie Sidle 31</title>
	</analytic>
	<monogr>
		<title level="m">Ricardo Rojas-Garcı ´a23</title>
				<editor>
			<persName><forename type="first">Michael</forename><surname>Sendtner</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Thomas</forename><surname>Meyer 39</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Martina</forename><surname>Wiedau-Pazos 5</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Catherine</forename><surname>Lomen-Hoerth 40</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Vivianna</forename><forename type="middle">M</forename><surname>Van Deerlin 41</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">John</forename><forename type="middle">Q</forename><surname>Trojanowski</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Lauren</forename><surname>Elman</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Leo</forename><surname>Mccluskey 42</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Nazli</forename><surname>Basak</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Thomas</forename><surname>Meitinger</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Peter</forename><surname>Lichtner 44</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Milena</forename><surname>Blagojevic-Radivojkov 44</surname></persName>
		</editor>
		<meeting><address><addrLine>Shuna Colville; Nicholas Wood; Jean-Franc¸ois Dartigues; Sandra; Silvana Penco; Nilo Riva; Albert C; Philip Van Damme; Robert H. Brown</addrLine></address></meeting>
		<imprint>
			<date>Vincent Meininger 19. Susana Pinto 20,21</date>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">93</biblScope>
		</imprint>
	</monogr>
	<note>Philippe Corcia. Vincenzo Silani 16,17 , Michael A. van Es 3 , R. Jeroen Pasterkamp 89 , Cathryn M. Lewis 90,91 &amp; Gerome Breen 6</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">17 Department of Pathophysiology and Tranplantation</title>
	</analytic>
	<monogr>
		<title level="m">18 Institut du Cerveau et de la Moelle e ´pinie `re, Inserm U1127, CNRS UMR 7225</title>
				<editor>
			<persName><forename type="first">Dino</forename><surname>Ferrari</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">'</forename><surname>Center</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">`</forename><surname>Universita</surname></persName>
		</editor>
		<editor>
			<persName><surname>Degli Studi Di Milano</surname></persName>
		</editor>
		<meeting><address><addrLine>Amsterdam, The Netherlands; Milano, Italy; Milano, Italy; Paris, France; Paris, France; Lisbon, Portugal; Lisbon, Portugal; Madrid, Spain</addrLine></address></meeting>
		<imprint/>
		<respStmt>
			<orgName>Commonwealth Scientific and Industrial Research Organisation, Sydney, New South Wales, Australia. 15 Department of Neurology ; 16 Department of Neurology and Laboratory of Neuroscience ; Sorbonne Universite ´s, UPMC Univ Paris 06 UMRS1127 ; Centre SLA Ile de France ; 20 Institute of Physiology and Institute of Molecular Medicine, University of Lisbon ; 21 Department of Neurosciences, Hospital de Santa Maria-CHLN</orgName>
		</respStmt>
	</monogr>
	<note>Hospital Carlos III</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">UK. 28 Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. 29 Sheffield Institute for Translational Neuroscience (SITraN)</title>
	</analytic>
	<monogr>
		<title level="j">Medical School Hannover</title>
		<imprint>
			<biblScope unit="issue">41</biblScope>
		</imprint>
		<respStmt>
			<orgName>Neurology Department, Hospital de la Santa Creu i Sant Pau de Barcelona, Autonomous University of Barcelona, Barcelona, Spain. 24 Department Neurology and Emory ALS Center, Emory University School of Medicine ; 25 Euan MacDonald Centre for Motor Neurone Disease Research, Edinburgh, UK. 26 Centre for Neuroregeneration and Medical Research Council Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK. 27 School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham ; Institute of Neurology, University College London, London, UK. 31 Department of Clinical Neuroscience, Institute of Neurology, University College London ; Institute of Neurology, University College London, London, UK. 33 Department of Neurodegenerative Diseases, Institute of Neurology, University College London, London, UK. 34 Centre for Neuroscience and Trauma, Blizard Institute, Queen Mary University of London ; 37 Department of Neurology, Otto-von-Guericke University Magdeburg ; 38 Institute for Clinical Neurobiology, University of Wu ¨rzburg, Wu ¨rzburg, Germany. 39 Charite ´University Hospital, Humboldt-University ; 40 Department of Neurology, University of California ; Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania ; 42 Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Pennsylvania, USA. 43 Neurodegeneration Research Laboratory, Bogazici University</orgName>
		</respStmt>
	</monogr>
	<note>36 Department of Neurology</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
	</analytic>
	<monogr>
		<title level="m">Helmholtz Zentrum Mu ¨nchen, Neuherberg, Germany. 45 INSERM U930</title>
				<meeting><address><addrLine>Tours, France</addrLine></address></meeting>
		<imprint/>
		<respStmt>
			<orgName>Universite ´Franc¸ois Rabelais</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">De</forename><surname>Aphp</surname></persName>
		</author>
		<author>
			<persName><surname>´partement De Pharmacologie Clinique</surname></persName>
		</author>
		<author>
			<persName><surname>Ho ˆpital De La Pitie ´-Salpe ˆtrie `re</surname></persName>
		</author>
		<author>
			<persName><surname>Pharmacologie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CNRS UMR</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="48" to="1127" />
		</imprint>
		<respStmt>
			<orgName>47 Department of Neurology, Ulm University ; Sorbonne Universite ´s</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<monogr>
		<title level="m" type="main">Institut du Cerveau et de la Moelle E ´pinie `re, Hoptial Salpe ˆtrie `re</title>
		<imprint>
			<pubPlace>Paris; Kiel, Germany</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Department of Medical Genetics ; 51 Department of Neurogenetics, Institute of Neurology, University College London, London, UK. 52 PopGen Biobank and Institute of Epidemiology, Christian Albrechts-University Kiel</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<title level="m" type="main">58 Division of Medical Genetics</title>
		<imprint>
			<pubPlace>Mannheim, Germany; Bonn, Germany; Bonn, Germany; Basel, Switzerland; Basel, Switzerland</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany. 54 Central Institute of Mental Health ; 55 Institute of Human Genetics, University of Bonn ; 56 Department of Genomics, Life and Brain Center ; 57 University Hospital Basel, University of Basel ; Department of Biomedicine, University of Basel</orgName>
		</respStmt>
	</monogr>
	<note>Medical Faculty Mannheim</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">71 Unit of Genetics of Neurodegenerative and Metabolic Diseases, Fondazione IRCCS Istituto Neurologico &apos;Carlo Besta</title>
		<idno>ISPED, Centre INSERM U897-Epidemiologie-Biostatistique &amp; CIC-1401</idno>
	</analytic>
	<monogr>
		<title level="m">73 Azienda Ospedaliera Citta `della Salute e della Scienza</title>
				<meeting><address><addrLine>Bordeaux, France; Rotterdam, The Netherlands; Rotterdam; London, London, UK.; Kantonsspital St Gallen, 9007 St Gallen, Switzerland; Pavia, Italy; Milan, Italy; Novara, Italy; Novara, Italy; Milano, Italy; Turin, Italy; Torino, Italy</addrLine></address></meeting>
		<imprint/>
		<respStmt>
			<orgName>Institute of Neuroscience and Medicine INM-1, Research Center Juelich, Juelich, Germany. 60 Lille University, INSERM U744, Institut Pasteur de Lille, Lille, France. 61 Bordeaux University ; CHU de Bordeaux, Pole de Sante Publique ; 66 Laboratory of Experimental Neurobiology, IRCCS &apos;C. Mondino&apos; National Institute of Neurology Foundation ; UPO, Universita `del Piemonte Orientale ; 69 Department of Neurosciences, University of Padova, Padova, Italy. 70 Department of Neurology, University of Eastern Piedmont ; Rita Levi Montalcini&apos; Department of Neuroscience, ALS Centre, University of Torino</orgName>
		</respStmt>
	</monogr>
	<note>The Netherlands. 64 MRC Social, Genetic and Developmental Psychiatry Centre, King&apos;s College London</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">75 NEMO Clinical Center, Serena Onlus Foundation, Niguarda Ca&apos; Granda Hostipal</title>
	</analytic>
	<monogr>
		<title level="j">Niguarda Ca&apos; Granda Hospital</title>
		<imprint/>
		<respStmt>
			<orgName>Department of Clinical research in Neurology, University of Bari &apos;A. Moro&apos;, at Pia Fondazione &apos;Card. G. Panico ; Department of Laboratory Medicine ; 77 Department of Neurology, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute</orgName>
		</respStmt>
	</monogr>
	<note>76 Medical Genetics Unit</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">88 Federation des Centres SLA Tours and Limoges, LITORALS, Tours, France. 89 Department of Translational Neuroscience</title>
	</analytic>
	<monogr>
		<title level="m">92 IoPPN Genomics &amp; Biomarker Core</title>
				<meeting><address><addrLine>Bari, Italy; Tricase, Lecce, Italy; Leuven Belgium; Worcester, Massachusetts, USA; Umeå, Sweden. 87 Centre SLA, CHRU de Tours, Tours, France; Utrecht, The Netherlands; Groningen, The Netherlands; King&apos;s College London, London, UK.; London, UK</addrLine></address></meeting>
		<imprint>
			<publisher>MRC Social</publisher>
			<biblScope unit="volume">84</biblScope>
		</imprint>
		<respStmt>
			<orgName>University Hospital &apos;Spedali Civili&apos;, Brescia, Italy. 79 Department of Neurology, Brighton and Sussex Medical School Trafford Centre for Biomedical Research, University of Sussex, Falmer, East Sussex, UK. 80 Laboratory of Neurological Diseases, Department of Neuroscience, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy. 81 Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari &apos;Aldo Moro ; Department of Clinical Research in Neurology, University of Bari &apos;Aldo Moro&apos;, at Pia Fondazione Cardinale G. Panico ; 83 Department of Neurology, University Hospital Leuven ; KU Leuven-University of Leuven, Department of Neurosciences, VIB-Vesalius Research Center, Leuven, Belgium. 85 Department of Neurology, University of Massachusetts Medical School ; 86 Department of Pharmacology and Clinical Neurosience, Umeå University ; University Medical Center Utrecht ; 90 Department of Genetics, University of Groningen, University Medical Centre Groningen ; Genetic and Developmental Psychiatry Centre, King&apos;s College London, London, UK. 93 NIHR Biomedical Research Centre for Mental Health, Maudsley Hospital and Institute of Psychiatry, Psychology &amp; Neuroscience, King&apos;s College London</orgName>
		</respStmt>
	</monogr>
	<note>Brain Center Rudolf Magnus. Schizophrenia Working Group of the Psychiatric Genomics Consortium</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Wiepke Cahn 4 , Guiqing Cai 127,128 , Dominique Campion 129 , Rita M. Cantor 5 , Vaughan J. Carr 130,131 , Noa Carrera 99 , Stanley V. Catts 130</title>
	</analytic>
	<monogr>
		<title level="m">Silviu A. Bacanu 115 , Martin Begemann 116 , Richard A. Belliveau Jr 95</title>
				<editor>
			<persName><forename type="first">Kimberley</forename><forename type="middle">D</forename><surname>Chambert 95</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Raymond</surname></persName>
		</editor>
		<editor>
			<persName><surname>Chan 133</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Ronald</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Eric</forename><forename type="middle">Y H</forename><surname>Chan 134</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Wei</forename><surname>Chen</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Eric</forename><forename type="middle">F C</forename><surname>Cheng 136</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Siow</forename><forename type="middle">Ann</forename><surname>Cheung 137</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">C</forename><forename type="middle">Robert</forename><surname>Chong 138</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">David</forename><surname>Cloninger 139</surname></persName>
		</editor>
		<editor>
			<persName><surname>Cohen 140</surname></persName>
		</editor>
		<meeting><address><addrLine>Nick Craddock; Timothy Dinan; Nelson B; Mark Hansen; Antonio Julia</addrLine></address></meeting>
		<imprint>
			<publisher>Frans A. Henskens</publisher>
			<date>Margot Albus 111</date>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page">58</biblScope>
		</imprint>
	</monogr>
	<note>Juha Karjalainen. David Kavanagh 99</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Mari Nelis 221 , Igor Nenadic 231 , Deborah A. Nertney 232 , Gerald Nestadt 233 , Kristin K. Nicodemus 234 , Liene Nikitina-Zake 194 , Laura Nisenbaum 235 , Annelie Nordin 236 , Eadbhard O&apos;Callaghan 237 , Colm O&apos;Dushlaine 95 , F. Anthony O&apos;Neill 238 , Sang-Yun Oh 239</title>
		<author>
			<persName><forename type="first">C</forename><surname>Matthew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">James</forename><forename type="middle">L</forename><surname>Keller 189</surname></persName>
		</author>
		<author>
			<persName><surname>Kennedy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Svetlana Limborska 193 , Carmel M. Loughland 130</title>
		<title level="s">Bertram Mu ¨ller-Myhsok</title>
		<editor>
			<persName><forename type="first">Stephanie</forename><surname>Williams 142</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Stephanie</forename><forename type="middle">H</forename><surname>Witt 166</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Aaron</forename><forename type="middle">R</forename><surname>Wolen 249</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Emily</forename><forename type="middle">H M</forename><surname>Wong 134</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Brandon</forename><forename type="middle">K</forename><surname>Wormley 115</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Hualin</forename><surname>Simon Xi 274</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Clement</forename><forename type="middle">C</forename><surname>Zai</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Xuebin</forename><surname>Zheng</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Fritz</forename><surname>Zimprich 262</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Naomi</forename><forename type="middle">R</forename><surname>Wray</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Kari</forename><surname>Stefansson 261</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Peter</forename><forename type="middle">M</forename><surname>Visscher</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Rolf</forename><surname>Adolfsson 236</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Ole</forename><forename type="middle">A</forename><surname>Andreassen</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Douglas</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Elvira</forename><surname>Blackwood</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Joseph</forename><forename type="middle">D</forename><surname>Bramon 276</surname></persName>
		</editor>
		<editor>
			<persName><surname>Buxbaum 127</surname></persName>
		</editor>
		<meeting><address><addrLine>Abraham Reichenberg 128 , Mark A. Reimers 249 , Alexander L. Richards; Pablo V. Gejman; Assen V; Bryan J. Mowry</addrLine></address></meeting>
		<imprint>
			<publisher>Kenneth S. Kendler</publisher>
			<date>190,191,192. Jan Lubinski 207. Milan Macek 197,198. Manuel Mattheisen 110,147,148,212. Andres Metspalu 221. Lili Milani 221. Jim Van Os 227. Jo Knight 190,191,192. Todd Lencz 284,285</date>
			<biblScope unit="volume">193</biblScope>
			<biblScope unit="page">100</biblScope>
		</imprint>
	</monogr>
	<note type="report_type">T. Scott Stroup 205</note>
	<note>Jennifer L. Moran. Aarno Palotie 97,246,289 , Carlos N. Pato 195 , Tracey L. Petryshen 214,289,290 , Danielle Posthuma 291,292,293 , Brien P. Riley 283 , Dan Rujescu 168,170 , Pak C. Sham 134,135,202 , Pamela Sklar 169,177,250 , David St Clair 294 , Daniel R. Weinberger 263,295 , Jens R. Wendland 251 , Thomas Werge 110,176,296 , Mark J. Daly 94 , Patrick F. Sullivan 119,142,245 &amp; Michael C. O&apos;Donovan</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Psychiatric and Neurodevelopmental Genetics Unit</title>
		<author>
			<persName><forename type="first">Massachusetts</forename><surname>Cambridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Usa</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Massachusetts General Hospital</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">110 The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Denmark. 111 State Mental Hospital, Haar, Germany. 112 Department of Psychiatry and Behavioral Sciences</title>
	</analytic>
	<monogr>
		<title level="j">Oslo, Norway. 108 Centre for Integrative Register-based Research</title>
		<imprint>
			<biblScope unit="issue">116</biblScope>
			<biblScope unit="page">107</biblScope>
		</imprint>
		<respStmt>
			<orgName>Neuropsychiatric Genetics Research Group, Department of Psychiatry, Trinity College, Dublin, Ireland. 99 MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK. 100 National Centre for Mental Health, Cardiff University, Cardiff, Wales. 101 Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, UK. 102 Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King&apos;s College London, London, UK. 103 Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, Lyngby, Denmark. 104 Division of Endocrinology and Center for Basic and Translational Obesity Research ; Institute of Clinical Medicine, University of Oslo ; CIRRAU, Aarhus University ; 109 National Centre for Register-based Research, Aarhus University ; Stanford University ; 114 Department of Psychiatry and Behavioral Sciences, Emory University ; Department of Psychiatry, Virginia Commonwealth University ; Max Planck Institute of Experimental Medicine, Go ¨ttingen, Germany. 117 Department of Medical Genetics, University of Pe ´cs, Pe ´cs, Hungary. 118 Szentagothai Research Center, University of Pe ´cs, Pe ´cs, Hungary. 119 Department of Medical Epidemiology and Biostatistics ; 120 Department of Psychiatry, University of Iowa Carver College of Medicine</orgName>
		</respStmt>
	</monogr>
	<note>Karolinska Institutet</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Athinoula A. Martinos Center, Massachusetts General Hospital</title>
		<imprint>
			<biblScope unit="issue">123</biblScope>
		</imprint>
		<respStmt>
			<orgName>University Medical Center Groningen, Department of Psychiatry, University of Groningen, The Netherlands. 122 School of Nursing, Louisiana State University Health Sciences Center</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">135 State Ket Laboratory for Brain and Cognitive Sciences, Li Ka Shing Faculty of Medicine</title>
	</analytic>
	<monogr>
		<title level="j">Janssen Research and Development</title>
		<imprint>
			<publisher>Chapel Hill</publisher>
		</imprint>
		<respStmt>
			<orgName>Center for Brain Science, Harvard University, Cambridge Massachusetts, USA. 125 Department of Psychiatry, Massachusetts General Hospital ; 126 Department of Psychiatry, University of California at San Francisco ; Icahn School of Medicine at Mount Sinai ; 128 Department of Psychiatry, Icahn School of Medicine at Mount Sinai ; University of New South Wales ; University of Queensland ; Chinese Academy of Science ; 134 Department of Psychiatry, Li Ka Shing Faculty of Medicine, The University of Hong Kong ; The University of Hong Kong ; 136 Department of Computer Science, University of North Carolina ; 138 Institute of Mental Health, Singapore. 139 Department of Psychiatry, Washington University ; 140 Department of Child and Adolescent Psychiatry, Pierre and Marie Curie Faculty of Medicine and Brain and Spinal Cord Institute (ICM)</orgName>
		</respStmt>
	</monogr>
	<note>New South Wales</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">District Of Columbia, USA. 166 Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health</title>
	</analytic>
	<monogr>
		<title level="m">171 Departments of Psychiatry and Human and Molecular Genetics</title>
				<editor>
			<persName><forename type="first">Pharma</forename><surname>Bioinformatics</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Early</forename><surname>Research</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">F</forename><surname>Development</surname></persName>
		</editor>
		<editor>
			<persName><surname>Hoffman-La Roche</surname></persName>
		</editor>
		<meeting><address><addrLine>Athens, Greece; Chicago, Illinois, USA; Evanston, Illinois, USA; London, London, UK; Skopje, Republic of Macedonia; Regensburg, Germany; Helsinki, Finland; Helsinki, Finland; Basel, Switzerland; Washington, District Of Columbia, USA; Los Angeles, California, USA; Richmond, Virginia, USA; Washington; Heidelberg, Germany; Aurora, Colorado, USA; Halle, Germany; New York, New York, USA; Munich, Germany; Paris, France; Moscow, Russia; Brisbane, Queensland, Australia; Amsterdam, The Netherlands; La Jolla, California, USA; Copenhagen, Denmark</addrLine></address></meeting>
		<imprint>
			<publisher>175 Illumina, Inc</publisher>
		</imprint>
		<respStmt>
			<orgName>Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA. 143 Department of Psychological Medicine, Queen Mary University of London, London, UK. 144 Molecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, UK. 145 Sheba Medical Center, Tel Hashomer, Israel. 146 Applied Molecular Genomics Unit, VI.B. Department of Molecular Genetics, University of Antwerp, Antwerp, Belgium. 147 Centre for Integrative Sequencing, iSEQ, Aarhus University, Aarhus, Denmark. 148 Department of Biomedicine, Aarhus University, Aarhus, Denmark. 149 First Department of Psychiatry, University of Athens Medical School ; 150 Department of Psychiatry, University College Cork, Ireland. 151 Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. 152 Cognitive Genetics and Therapy Group, School of Psychology and Discipline of Biochemistry, National University of Ireland Galway, Ireland. 153 Department of Psychiatry and Behavioral Neuroscience, University of Chicago ; NorthShore University HealthSystem ; University Clinic of Psychiatry ; 157 Department of Psychiatry, University of Regensburg ; Helsinki University Central Hospital ; 162 Department of Psychiatry, Georgetown University School of Medicine ; 163 Department of Psychiatry, Keck School of Medicine of the University of Southern California ; 164 Department of Psychiatry, Virginia Commonwealth University School of Medicine ; University of Heidelberg ; 167 Department of Psychiatry, University of Colorado Denver ; 168 Department of Psychiatry, University of Halle ; Department of Psychiatry, Icahn School of Medicine at Mount Sinai ; 170 Department of Psychiatry, University of Munich ; INSERM, Institut de Myologie, Ho ˆpital de la Pitie `-Salpe ˆtrie `re ; 173 Queensland Brain Institute, The University of Queensland ; 174 Academic Medical Centre University of Amsterdam, Department of Psychiatry</orgName>
		</respStmt>
	</monogr>
	<note>Russian Academy of Medical Sciences. 176 Institute of Biological Psychiatry, MH.C. Sct. Hans, Mental Health Services</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">JJ Peters V.A. Medical Center</title>
		<imprint>
			<biblScope unit="page">178</biblScope>
		</imprint>
		<respStmt>
			<orgName>Friedman Brain Institute, Icahn School of Medicine at Mount Sinai</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Latvian Biomedical Research and Study Centre, Riga, Latvia. 195 Department of Psychiatry and Zilkha Neurogenetics Institute</title>
	</analytic>
	<monogr>
		<title level="j">Department of Biology and Medical Genetics</title>
		<imprint>
			<date type="published" when="0199">194. 196. 197. 198. 199</date>
		</imprint>
		<respStmt>
			<orgName>Priority Research Centre for Health Behaviour, University of Newcastle, Newcastle, Australia. 180 School of Electrical Engineering and Computer Science, University of Newcastle ; Department of Clinical Biochemistry ; 183 Department of Psychiatry, Fujita Health University School of Medicine ; Department of Psychiatry, Stavanger University Hospital, Stavanger, Norway. 185 Rheumatology Research Group, Vall d&apos;Hebron Research Institute ; The University of Western Australia ; The University of Western Australia ; 188 Department of Medical Genetics, Medical University, Sofia, Bulgaria. 189 Department of Psychology, University of Colorado Boulder ; 191 Department of Psychiatry, University of Toronto ; 192 Institute of Medical Science, University of Toronto ; Keck School of Medicine at University of Southern California ; Faculty of Medicine, Vilnius University ; Second Faculty of Medicine and University Hospital Motol ; Charles University Prague ; Pierre and Marie Curie Faculty of Medicine ; NUS Graduate Medical School, Singapore. 201 Department of Psychiatry, Hadassah-Hebrew University Medical Center ; Li Ka Shing Faculty of Medicine, The University of Hong Kong</orgName>
		</respStmt>
	</monogr>
	<note>Russian Academy of Sciences. 202 Centre for Genomic Sciences</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">211 Centre National de la Recherche Scientifique, Laboratoire de Ge ´ne ´tique Mole ´culaire de la Neurotransmission et des Processus Neurode ´ge ´ne ´ratifs, Ho ˆpital de la Pitie ´Salpe ˆtrie `re</title>
	</analytic>
	<monogr>
		<title level="j">Pomeranian Medical University in Szczecin</title>
		<imprint/>
		<respStmt>
			<orgName>Mental Health Centre and Psychiatric Laboratory, West China Hospital, Sichuan University, Chendu, Sichuan, China. 204 Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health ; Columbia University ; University of Newcastle ; Johns Hopkins University ; 210 Department of Psychiatry, University of Bonn ; 212 Department of Genomics Mathematics, University of Bonn ; 216 Department of Psychiatry, National University of Ireland Galway, Ireland. 217 Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK. 218 Division of Psychiatry, University of Edinburgh ; Oslo University Hospital, Oslo, Norway. 220 Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel Deaconess Medical Center ; University of Tartu, Tartu, Estonia. 222 School of Psychology, University of Newcastle</orgName>
		</respStmt>
	</monogr>
	<note>219 Division of Mental Health and Addiction. 221 Estonian Genome Center</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">231 Department of Psychiatry and Psychotherapy</title>
	</analytic>
	<monogr>
		<title level="m">233 Department of Psychiatry and Behavioral Sciences</title>
				<meeting><address><addrLine>Munich, Germany; Munich, Germany; Jena, Germany; Brisbane, Queensland, Australia; Baltimore, Maryland, USA; Trinity College Dublin, Dublin, Ireland; Indianapolis, Indiana, USA; Umeå, Sweden; Blackrock, Dublin, Ireland; Berkeley, California, USA; London, UK</addrLine></address></meeting>
		<imprint>
			<publisher>238 Centre for Public Health</publisher>
		</imprint>
		<respStmt>
			<orgName>First Psychiatric Clinic, Medical University, Sofia, Bulgaria. 224 Department P, Aarhus University Hospital, Risskov, Denmark. 225 Department of Psychiatry, Royal College of Surgeons in Ireland, Ireland. 226 King&apos;s College London, London, UK. 227 Maastricht University Medical Centre, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht, The Netherlands. 228 Institute of Translational Medicine, University Liverpool, UK. 229 Max Planck Institute of Psychiatry ; Jena University Hospital ; 232 Department of Psychiatry, Queensland Brain Institute and Queensland Centre for Mental Health Research, University of Queensland ; Johns Hopkins University School of Medicine ; 236 Department of Clinical Sciences, Psychiatry, Umeå University ; Institute of Clinical Sciences, Queens University Belfast, Belfast, UK. 239 Lawrence Berkeley National Laboratory, University of California at Berkeley</orgName>
		</respStmt>
	</monogr>
	<note>237 DETECT Early Intervention Service for Psychosis. 240 Institute of Psychiatry at King&apos;s College London</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">249 Virginia Institute for Psychiatric and Behavioral Genetics</title>
	</analytic>
	<monogr>
		<title level="j">PharmaTherapeutics Clinical Research</title>
		<imprint>
			<biblScope unit="volume">252</biblScope>
			<biblScope unit="page">251</biblScope>
		</imprint>
		<respStmt>
			<orgName>Melbourne Neuropsychiatry Centre, University of Melbourne &amp; Melbourne Health, Melbourne, Australia. 242 Department of Psychiatry, University of Helsinki, Finland. 243 Public Health Genomics Unit, National Institute for Health and Welfare ; University of Belgrade, Belgrade, Serbia. 245 Department of Psychiatry, University of North Carolina, Chapel Hill, North Carolina, USA. 246 Institute for Molecular Medicine Finland, FIMM, Helsinki, Finland. 247 Department of Epidemiology, Harvard University ; 248 Department of Psychiatry, University of Oxford ; Virginia Commonwealth University ; Icahn School of Medicine at Mount Sinai ; Pfizer Worldwide Research and Development ; Department of Psychiatry and Psychotherapy, University of Gottingen, Go ¨ttingen</orgName>
		</respStmt>
	</monogr>
	<note>250 Institute for Multiscale Biology</note>
</biblStruct>

<biblStruct xml:id="b61">
	<monogr>
		<title level="m" type="main">256 Division of Cancer Epidemiology and Genetics, National Cancer Institute</title>
		<imprint>
			<publisher>Bronx Veterans Affairs Medical Center</publisher>
			<pubPlace>Newcastle, Australia; Bethesda, Maryland, USA; Reykjavik, Iceland; Tbilisi, Georgia; New York, New York, USA</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Psychiatry and Psychotherapy Clinic, University of Erlangen, Erlangen, Germany. 254 Hunter New England Health Service, Newcastle, Australia. 255 School of Biomedical Sciences, University of Newcastle ; 257 University of Iceland, Landspitali, National University Hospital ; Tbilisi State Medical University (TSMU)</orgName>
		</respStmt>
	</monogr>
	<note>258 Department of Psychiatry and Drug Addiction. 259 Research and Development</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">263 Lieber Institute for Brain Development</title>
	</analytic>
	<monogr>
		<title level="j">University Medical Centre</title>
		<imprint>
			<biblScope unit="volume">265</biblScope>
		</imprint>
		<respStmt>
			<orgName>Wellcome Trust Centre for Human Genetics, Oxford, UK. 261 deCODE Genetics, Reykjavik, Iceland. 262 Department of Clinical Neurology, Medical University of Vienna ; Magnus Institute of Neuroscience, University Medical Centre Utrecht</orgName>
		</respStmt>
	</monogr>
	<note>264 Department of Medical Genetics</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">273 Department of Psychological Medicine and Neurology, MR.C. Centre for Neuropsychiatric Genetics and Genomics</title>
	</analytic>
	<monogr>
		<title level="j">Queen Elizabeth I.I. Medical Centre</title>
		<imprint/>
		<respStmt>
			<orgName>Berkshire Healthcare NH.S. Foundation Trust, Bracknell, UK. 267 Section of Psychiatry, University of Verona ; 268 Department of Psychiatry, University of Oulu, Oulu, Finland. 269 University Hospital of Oulu ; School of Medicine, Cardiff University ; Pfizer Worldwide Research and Development</orgName>
		</respStmt>
	</monogr>
	<note>272 Department of Psychiatry and Clinical Neurosciences, School of Psychiatry and Clinical Neurosciences. 275 Human Genetics, Genome Institute of Singapore</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">282 UWA Centre for Clinical Research in Neuropsychiatry. 283 Virginia Institute for Psychiatric and Behavioral Genetics, Departments of Psychiatry and Human and Molecular Genetics</title>
		<author>
			<persName><forename type="first">F</forename><surname>Hoffman-La Roche</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Feinstein Institute for Medical Research</title>
		<imprint>
			<biblScope unit="issue">284</biblScope>
		</imprint>
		<respStmt>
			<orgName>University College London, London, UK. 277 Department of Neuroscience, Icahn School of Medicine at Mount Sinai ; 278 Department of Genetics, The Hebrew University of Jerusalem ; The University of Western Australia</orgName>
		</respStmt>
	</monogr>
	<note>279 Neuroscience Discovery and Translational Area, Pharma Research and Early Development. 285 The Hofstra NS-LIJ School of Medicine</note>
</biblStruct>

<biblStruct xml:id="b65">
	<monogr>
		<title level="m" type="main">287 Saw Swee Hock School of Public Health</title>
		<imprint>
			<pubPlace>Glen Oaks, New York, USA; Singapore</pubPlace>
		</imprint>
		<respStmt>
			<orgName>National University of Singapore</orgName>
		</respStmt>
	</monogr>
	<note>The Zucker Hillside Hospital</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">292 Department of Complex Trait Genetics, Neuroscience Campus Amsterdam</title>
	</analytic>
	<monogr>
		<title level="m">289 The Broad Institute of MI.T. and Harvard</title>
				<meeting><address><addrLine>Brisbane, Queensland, Australia; Cambridge, Massachusetts, USA; Boston, Massachusetts, USA; Rotterdam, The Netherlands; Amsterdam, The Netherlands; Neuroscience Campus Amsterdam; Amsterdam, The Netherlands</addrLine></address></meeting>
		<imprint/>
		<respStmt>
			<orgName>Queensland Centre for Mental Health Research, University of Queensland ; Erasmus University Medical Centre ; University Medical Center Amsterdam ; Center for Neurogenomics and Cognitive Research ; VU University</orgName>
		</respStmt>
	</monogr>
	<note>293 Department of Functional Genomics</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">295 Departments of Psychiatry</title>
	</analytic>
	<monogr>
		<title level="j">Neuroscience and Institute of Genetic Medicine</title>
		<imprint/>
		<respStmt>
			<orgName>University of Aberdeen, Institute of Medical Sciences ; 296 Department of Clinical Medicine, University of Copenhagen</orgName>
		</respStmt>
	</monogr>
	<note>Johns Hopkins School of Medicine</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
